Publication & Citation Trends
Publications
0 total
Abstract PR13: Adjuvant TLR-3 administration enhances proinflammatory immune responses and is associated with extended survival in glioblastoma patients treated with dendritic cell vaccination
Cited by 0
Semantic Scholar
ATIM-39. IMPROVED SURVIVAL NOTED IN GLIOBLASTOMA PATIENTS TREATED WITH ADJUVANT TLR-3 AGONIST IN SETTING OF AUTOLOGOUS LYSATE-PULSED DC VACCINATION OA
Cited by 2
Semantic Scholar
Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma OA
Cited by 187
Semantic Scholar
TMIC-16. TUMOR-INFILTRATING MYELOID CELLS MEDIATE ADAPTIVE IMMUNE RESISTANCE IN GLIOBLASTOMA OA
Cited by 0
Semantic Scholar
ATIM-32. PHASE IIA CLINICAL TRIAL EVALUATING DENDRITIC CELL VACCINE FOR THE TREATMENT OF LOW-GRADE GLIOMAS OA
Cited by 2
Semantic Scholar
IMMUNOTHERAPY/BIOLOGICAL THERAPIES OA
Cited by 3
Semantic Scholar
It-007. Cytotoxic T Cell Functional Responsiveness May Predict Clinical Efficacy Of Dendritic Cell Vaccination In Glioblastoma Patients
Cited by 0
Semantic Scholar
Research Topics
Immunotherapy and Immune Responses
(21)
Cancer Immunotherapy and Biomarkers
(11)
Glioma Diagnosis and Treatment
(7)
CAR-T cell therapy research
(7)
T-cell and B-cell Immunology
(3)
Affiliations
APLA Health
University of California, Los Angeles
UCLA Health
Oxford University Press (United Kingdom)
Northwest Biotherapeutics (United States)